| Tumor immunotherapy by epicutaneous immunization requires langerhans cells P Stoitzner, LK Green, JY Jung, KM Price, CH Tripp, B Malissen, ... The Journal of Immunology 180 (3), 1991-1998, 2008 | 111 | 2008 |
| Inefficient presentation of tumor-derived antigen by tumor-infiltrating dendritic cells P Stoitzner, LK Green, JY Jung, KM Price, H Atarea, B Kivell, F Ronchese Cancer Immunology, Immunotherapy 57 (11), 1665-1673, 2008 | 108 | 2008 |
| Treatment with the Antipsychotic Agent, Risperidone, Reduces Disease Severity in Experimental Autoimmune Encephalomyelitis D O'Sullivan, L Green, S Stone, P Zareie, M Kharkrang, D Fong, B Connor, ... PLOS ONE 9 (8), e104430, 2014 | 65 | 2014 |
| Targeted mutagenesis of the Vibrio fischeri flavin reductase FRase I to improve activation of the anticancer prodrug CB1954 PM Swe, JN Copp, LK Green, CP Guise, AM Mowday, JB Smaill, ... Biochemical pharmacology 84 (6), 775-783, 2012 | 37 | 2012 |
| The Flavin Reductase MsuE Is a Novel Nitroreductase that Can Efficiently Activate Two Promising Next-Generation Prodrugs for Gene-Directed Enzyme Prodrug Therapy LK Green, MA Storey, EM Williams, AV Patterson, JB Smaill, JN Copp, ... Cancers 5 (3), 985-997, 2013 | 32 | 2013 |
| Pseudomonas aeruginosa MdaB and WrbA are water-soluble two-electron quinone oxidoreductases with the potential to defend against oxidative stress LK Green, AC La Flamme, DF Ackerley Journal of Microbiology 52 (9), 771-777, 2014 | 28 | 2014 |
| Pseudomonas aeruginosa NfsB and nitro-CBI-DEI–a promising enzyme/prodrug combination for gene directed enzyme prodrug therapy LK Green, SP Syddall, KM Carlin, GD Bell, CP Guise, AM Mowday, ... Molecular cancer 12 (1), 1, 2013 | 19 | 2013 |
| In Vitro and in Vivo Characterisation of P. Aeruginosa Oxidoreductase Enzymes in Pathogenesis and Therapy LK Green Victoria University of Wellington, 2012 | 1 | 2012 |
